Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?

Ann Oncol. 2013 May;24(5):1415-6. doi: 10.1093/annonc/mdt102. Epub 2013 Mar 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Intestinal Neoplasms / diagnosis*
  • Neoplasms, Hormone-Dependent / diagnosis*
  • Neuroendocrine Tumors / diagnosis*
  • Pancreatic Neoplasms / diagnosis*
  • Stomach Neoplasms / diagnosis*